Literature DB >> 4125204

Dexamethasone in herpes-simplex encephalitis.

A H Habel, J K Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4125204     DOI： 10.1016/s0140-6736(72)90505-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 2.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 3.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

4.  CSF herpes virus and autoantibody profiles in the evaluation of encephalitis.

Authors:  Jenny J Linnoila; Matthew J Binnicker; Masoud Majed; Christopher J Klein; Andrew McKeon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-01

5.  The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  U Meyding-Lamadé; C Jacobi; F Martinez-Torres; T Lenhard; B Kress; M Kieser; C Klose; K Einhäupl; J Bösel; M-B Mackert; V Homberg; C Koennecke; G Weißheit; D Claus; B Kieseier; J Bardutzky; T Neumann-Haefelin; M W Lorenz; H Steinmetz; C Gerloff; D Schneider; A Grau; M Klein; R Dziewas; U Bogdahn; W Jakob; R Linker; K Fuchs; A Sander; S Luntz; T Hoppe-Tichy; D F Hanley; R von Kummer; E Craemer
Journal:  Neurol Res Pract       Date:  2019-09-12

6.  Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Authors:  Francisco Martinez-Torres; Sanjay Menon; Maria Pritsch; Norbert Victor; Ekkehart Jenetzky; Katrin Jensen; Eva Schielke; Erich Schmutzhard; Jan de Gans; Chin-Hee Chung; Steffen Luntz; Werner Hacke; Uta Meyding-Lamadé
Journal:  BMC Neurol       Date:  2008-10-29       Impact factor: 2.474

7.  Fulminant Herpes Simplex Virus Type I Encephalitis Despite Maximal Medical Therapy.

Authors:  Nakul Katyal; Ather M Taqui; Deborah Tepper; Jonathan M Beary; Christopher R Newey
Journal:  Cureus       Date:  2018-04-12

8.  Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis.

Authors:  Thomas Whitfield; Cristina Fernandez; Kelly Davies; Sylviane Defres; Michael Griffiths; Cory Hooper; Rebecca Tangney; Girvan Burnside; Anna Rosala-Hallas; Perry Moore; Kumar Das; Mark Zuckerman; Laura Parkes; Simon Keller; Neil Roberts; Ava Easton; Saber Touati; Rachel Kneen; J P Stahl; Tom Solomon
Journal:  BMJ Open       Date:  2021-07-22       Impact factor: 2.692
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.